0001104659-24-062663.txt : 20240516 0001104659-24-062663.hdr.sgml : 20240516 20240516193124 ACCESSION NUMBER: 0001104659-24-062663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240514 FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Herskowitz Neil CENTRAL INDEX KEY: 0001298246 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38128 FILM NUMBER: 24957357 MAIL ADDRESS: STREET 1: 2109 BROADWAY, SUITE 206 CITY: NEW YORK STATE: NY ZIP: 10023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc. CENTRAL INDEX KEY: 0001651407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472568632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 95 SAWYER ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 95 SAWYER ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 tm2414703-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-05-14 0 0001651407 Checkpoint Therapeutics, Inc. CKPT 0001298246 Herskowitz Neil 95 SAWYER ROAD, SUITE 110 WALTHAM MA 02453 1 0 0 0 0 COMMON STOCK 2024-05-14 4 A 0 32051 0.00 A 67174 D COMMON STOCK 2024-05-14 4 A 0 50000 0.00 A 117174 D The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Herskowitz's continued service on the board on such date. Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board. The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Herskowitz's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029. /s/ James F. Oliviero, Attorney-in-Fact 2024-05-16